[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
[1]Peking University People’s Hospital;
Peking University Institute of Hematology;
Beijing 100044;
China;
high risk AML; haplo stem cell transplantation; matched sibling donor transplantation; complex/monosomy chromosomal karyotype;